Polyomaviruses

Infectious Diseases: Third Edition

Volumn 2, Issue , 2010, Pages 1570-1572

  Viscidi, Raphael P ^a   Shah, Keerti V ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84941068698     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-323-04579-7.00157-X     Document Type: Chapter

References (21)

1. Padgett B.L., Walker D.L., ZuRhein G.M., et al. Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy. Lancet 1971, 1:1257-1260.
2. Gardner S.D., Field A.M., Coleman D.V., et al. New human papovavirus (B.K.) isolated from urine after renal transplantation. Lancet 1971, 1:1253-1257.
3. Allander T., Andreasson K., Gupta S., et al. Identification of a third human polyomavirus. J Virol 2007, 81:4130-4136.
4. Gaynor A.M., Nissen M.D., Whiley D.M., et al. Identification of a novel polyomavirus from patients with acute respiratory tract infections. PLoS Pathog 2007, 3:e64.
5. Feng H., Shuda M., Chang Y., et al. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 2008, 319:1096-10100.
6. Elphick G.F., Querbes W., Jordan J.A., et al. The human polyomavirus, JCV, uses serotonin receptors to infect cells. Science 2004, 306:1380-1383.
7. Stolt A., Sasnauskas K., Koskela P., et al. Seroepidemiology of the human polyomaviruses. J Gen Virol 2003, 84:1499-1504.
8. Ling P.D., Lednicky J.A., Keitel W.A., et al. The dynamics of herpesvirus and polyomavirus reactivation and shedding in healthy adults: a 14-month longitudinal study. J Infect Dis 2003, 187:1571-1580.
9. White F.A., Ishaq M., Stoner G.L., et al. JC virus DNA is present in many human brain samples from patients without progressive multifocal leukoencephalopathy. J Virol 1992, 66:5726-5734.
10. Viscidi R.P., Rollison D.E., Viscidi E., et al. Serological cross-reactivities between antibodies to simian virus 40, BK virus, and JC virus assessed by virus-like-particle-based enzyme immunoassays. Clin Diagn Lab Immunol 2003, 10:278-285.
11. Major E.O., Amemiya K., Tornatore C.S., et al. Pathogenesis and molecular biology of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain. Clin Microbiol Rev 1992, 5:49-73.
12. Yousry T.A., Major E.O., Ryschkewitsch C., et al. Evaluation of patients treated with natalizumab for progressive multifocal leukoencephalopathy. N Engl J Med 2006, 354:924-933.
13. De Luca A., Giancola M.L., Ammassari A., et al. The effect of potent antiretroviral therapy and JC virus load in cerebrospinal fluid on clinical outcome of patients with AIDS-associated progressive multifocal leukoencephalopathy. J Infect Dis 2000, 182:1077-1083.
14. Whiteman M.L., Post M.J., Berger J.R., et al. Progressive multifocal leukoencephalopathy in 47 HIV-seropositive patients: neuroimaging with clinical and pathologic correlation. Radiology 1993, 187:233-240.
15. Bossolasco S., Calori G., Moretti F., et al. Prognostic significance of JC virus DNA levels in cerebrospinal fluid of patients with HIV-associated progressive multifocal leukoencephalopathy. Clin Infect Dis 2005, 40:738-744.
16. Hirsch H.H., Knowles W., Dickenmann M., et al. Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients. N Engl J Med 2002, 347:488-496.
17. Drachenberg C.B., Hirsch H.H., Ramos E., et al. Polyomavirus disease in renal transplantation: review of pathological findings and diagnostic methods. Hum Pathol 2005, 36:1245-1255.
18. Randhawa P., Ho A., Shapiro R., et al. Correlates of quantitative measurement of BK polyomavirus (BKV) DNA with clinical course of BKV infection in renal transplant patients. J Clin Microbiol 2004, 42:1176-1180.
19. Dropulic L.K., Jones R.J. Polyomavirus BK infection in blood and marrow transplant recipients. Bone Marrow Transplant 2008, 41:11-18.
20. Imperiale M.J. The human polyomaviruses, BKV and JCV: molecular pathogenesis of acute disease and potential role in cancer. Virology 2000, 267:1-7.
21. Brennan D.C., Agha I., Bohl D.L., et al. Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction. Am J Transplant 2005, 5:582-594.